ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OPTI Optibiotix Health Plc

16.25
0.00 (0.00%)
Last Updated: 08:00:06
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.25 15.50 17.00 16.45 16.25 16.25 8,881 08:00:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.72 14.82M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 16.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £14.82 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.72.

Optibiotix Health Share Discussion Threads

Showing 28601 to 28622 of 147775 messages
Chat Pages: Latest  1147  1146  1145  1144  1143  1142  1141  1140  1139  1138  1137  1136  Older
DateSubjectAuthorDiscuss
04/9/2017
22:38
SBTX Dr Catherine O’Neill mention. - PROBIOTICS MAY REPLACE ANTIBIOTICS IN THE FUTURE -
loungeact
04/9/2017
21:25
Good to see SBTX creeping up. Nicely poised now ahead of news, which much be imminent (trial plans and manufacturing scale up news). Given how little free float there is and the lock in period for 60%+ of share register it could really fly!
trotterstrading
04/9/2017
18:59
Thanks, will review.
affemoose
04/9/2017
18:47
Healthy ageing article by our very own Peter Wennström

Successes and Failures in Healthy Aging Product Launches

parob
04/9/2017
16:09
https://www.probiotaevent.com/wp-content/uploads/2017/02/SCIENTIFIC-FRONTIERS-ABSTRACTS.pdfAffe - Above abstracts shown at probiota 2017. Number 4 & 12 are optis studies. Note these were done independently by reading university professor glen gibson world key opinion leader in this field. This should be published in a mainstream journal shortly.Slimbiome is made up of 3 ingredients: glucomannan, oligofructose and chromium piccolonate. These ingredients are sold separately and individually have many scientific claims. optis patent protects the unique combination of the ingredients. The oligofructose will be replaced with more targeted prebiotics in the future using optis optibiotic platform. People tend to view optis weigh management division as simply slimbiome but there's much more to come.
riskybusiness1
04/9/2017
15:58
AffeMoose, have you looked at the OPTI website, read the RNS's going back along etc etc?
rafboy
04/9/2017
15:52
SBTX is another SOH backed incubator project that is likely to make huge returns for investors who enter at current share price levels imo...low cash burn, high demand products once tested and approved.
ibug
04/9/2017
14:55
SBTX breaking out...
parob
04/9/2017
14:26
Way over 80 Zebbo :)
judijudi
04/9/2017
13:32
Yep, they will be buying them back at 80...lol
zebbo
04/9/2017
13:17
Wonder who that is hey scotty?
:)

judijudi
04/9/2017
13:12
Probably the same person that was buying blocks in the 50's and 60's now taking a nice profit!
f3rdinand
04/9/2017
13:09
somebody really knocking them out today
fools

judijudi
04/9/2017
11:01
judijudi ..yep but each share at least is one less they hold

and hopefully higher lows here continues

onedayrodders
04/9/2017
11:00
Thanks kipper, will have a look.
rafboy
04/9/2017
10:56
O/T. I have been invested in OPTI for about 2 years and as a LT holder I feel very confident about this investment. I have learn a lot from all the intelligent regulars on this BB, especially Elrico for his in-depth analysis, so I would like to contribute something in return.

I have been looking out for other L/T investment opportunities and have invested in Destiny Pharma (DEST) that IPOed on AIM this morning. I see this as being a similar opportunity to OPTI (albeit a much larger MCAP at IPO)in that it has developed significant IP that could open up a massive market opportunity. In the case of DEST, the opportunity is to develop the first drug that is resistant to MRSA and other super bugs. There's a heap of stuff on the net about this topic but most in the pharma world agree that this is the BIG one, so if DEST can crack it, it will become a billion dollar company, IMHO. Like OPTI this is a jam tomorrow opportunity and the jam will probably be 2 years later than OPTI. The inflection point will only be after successful Phase 3 clinical trials, which are more than 2 years away.

This is just a heads up - please do your own research and good luck.

kipper1960
04/9/2017
10:34
Our seller is offloading great chunks again I see.
jestercat2
04/9/2017
10:22
Ha ha.
First time on a yacht, so a bit nervous.
John

2350220
04/9/2017
10:04
Enjoy the monastery 2350220 !
luminoso
04/9/2017
09:29
Not the nicest way to refer to your beloved, Diamond :)
owenmo
04/9/2017
09:11
I'll be out of contact for a whole week.
How will I get my hourly Opti fix?
Let's hope that I come back to a nice surprise :-)

All the best,
John

2350220
04/9/2017
08:47
Problems also this morning when I tried to get out of tern..that has cost me !!
bobdown2
Chat Pages: Latest  1147  1146  1145  1144  1143  1142  1141  1140  1139  1138  1137  1136  Older

Your Recent History

Delayed Upgrade Clock